T 0990/23 (VERTEX PHARMACEUTICALS / CFTR MODULATORS) of 10.03.2025

European Case Law Identifier: ECLI:EP:BA:2025:T099023.20250310
Date of decision: 10 March 2025
Case number: T 0990/23
Petition for review of: -
Application number: 15849396.5
IPC class: C07D 209/18 A61K 31/18 C07D 413/14 C07D 213/64 C07D 401/04 C07D 231/20 C07D 235/24 C07D 403/12 C07D 209/49 C07D 239/34 A01N 41/06 C07D 407/12 C07D 213/73 C07D 403/10
Language of proceedings: English
Distribution: No distribution (D)
Download: Decision in English
OJ versions: No OJ links found
Other decisions for this case: -
Abstracts for this decision: -
Application title: MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
Applicant name: Vertex Pharmaceuticals Incorporated
Opponent name: Generics [UK] Limited
Board: 3.3.02
Headnote: -
Relevant legal provisions: European Patent Convention Art 100(a)European Patent Convention Art 100(b)European Patent Convention Art 100(c)European Patent Convention Art 56
Keywords: Grounds for opposition - added subject-matter (no)
Grounds for opposition - insufficiency of disclosure (no)
Inventive step (yes)
Catchword: -
Cited cases: G 0003/14 T 0939/92 T 0415/11 T 0465/19
Citing cases: -

Order

For these reasons it is decided that:

The appeal is dismissed.